Minimal Changes in Urine Markers of Tubular Dysfunction in CHB Patients Receiving Tenofovir alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF)

被引：0

作者：

Lim, Young-Suk ^{[2
]}

Ide, Tatsuya ^{[3
]}

Strasser, Simone I. ^{[4
]}

Yoon, Ki Tae ^{[5
]}

Paik, Seung Woon ^{[6
]}

Flaherty, John F. ^{[1
]}

Kim, Kyungpil ^{[1
]}

Gaggar, Anuj ^{[1
]}

Subramanian, Mani ^{[1
]}

Mangia, Alessandra ^{[7
]}

Simon, Krzysztof ^{[8
]}

Kwan, Peter ^{[9
]}

Gane, Edward J. ^{[10
]}

机构：

[1] Gilead Sci, Foster City, CA USA

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Gastroenterol, Songpa, South Korea

[3] Kurume Univ Hosp, Div Gastroenterol, Kurume, Fukuoka, Japan

[4] Royal Prince Alfred Hosp, AW Morrow GI & Liver Ctr, Camperdown, New Zealand

[5] Pusan Natl Univ Hosp, Pusan, South Korea

[6] Samsung Med Ctr, Med, Seoul, South Korea

[7] Casa Sollievo Sofferenza, Liver Unit, San Giovanni Rotondo, Italy

[8] Klin Chorob Zakaznych AM, Dept Infect Dis Hepatol & Acquired Immundeficienc, Wroclaw, Poland

[9] Univ British Columbia, Gordon & Leslie Diamond Ctr, Vancouver, BC, Canada

[10] Auckland City Hosp, Auckland, New Zealand

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1901

引用

页码：940A / 940A

页数：1